133 related articles for article (PubMed ID: 7776819)
1. A novel electrophilic high affinity irreversible probe for the cannabinoid receptor.
Morse KL; Fournier DJ; Li X; Grzybowska J; Makriyannis A
Life Sci; 1995; 56(23-24):1957-62. PubMed ID: 7776819
[TBL] [Abstract][Full Text] [Related]
2. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.
Howlett AC; Champion TM; Wilken GH; Mechoulam R
Neuropharmacology; 1990 Feb; 29(2):161-5. PubMed ID: 2158635
[TBL] [Abstract][Full Text] [Related]
3. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
4. Detection of cannabinoid receptors by photoaffinity labelling.
Burstein SH; Audette CA; Charalambous A; Doyle SA; Guo Y; Hunter SA; Makriyannis A
Biochem Biophys Res Commun; 1991 Apr; 176(1):492-7. PubMed ID: 1850270
[TBL] [Abstract][Full Text] [Related]
5. (-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor.
Picone RP; Khanolkar AD; Xu W; Ayotte LA; Thakur GA; Hurst DP; Abood ME; Reggio PH; Fournier DJ; Makriyannis A
Mol Pharmacol; 2005 Dec; 68(6):1623-35. PubMed ID: 16157695
[TBL] [Abstract][Full Text] [Related]
6. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ
Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective synthesis and pharmacology of 11-hydroxy-(1'S,2'R)-dimethylheptyl-delta 8-THC.
Liddle J; Huffman JW; Wiley JL; Martin BR
Bioorg Med Chem Lett; 1998 Aug; 8(16):2223-6. PubMed ID: 9873517
[TBL] [Abstract][Full Text] [Related]
8. (-)-11-Hydroxy-7'-isothiocyanato-1',1'-dimethylheptyl-delta 8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain.
Guo Y; Abadji V; Morse KL; Fournier DJ; Li X; Makriyannis A
J Med Chem; 1994 Nov; 37(23):3867-70. PubMed ID: 7966145
[No Abstract] [Full Text] [Related]
9. A novel probe for the cannabinoid receptor.
Devane WA; Breuer A; Sheskin T; Järbe TU; Eisen MS; Mechoulam R
J Med Chem; 1992 May; 35(11):2065-9. PubMed ID: 1317925
[TBL] [Abstract][Full Text] [Related]
10. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.
Devlin MG; Christopoulos A
J Neurochem; 2002 Mar; 80(6):1095-102. PubMed ID: 11953460
[TBL] [Abstract][Full Text] [Related]
12. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
Huffman JW; Liddle J; Yu S; Aung MM; Abood ME; Wiley JL; Martin BR
Bioorg Med Chem; 1999 Dec; 7(12):2905-14. PubMed ID: 10658595
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.
Martin BR; Compton DR; Prescott WR; Barrett RL; Razdan RK
Drug Alcohol Depend; 1995 Mar; 37(3):231-40. PubMed ID: 7796717
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of halogenated delta 8-THC analogs.
Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A
Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915
[TBL] [Abstract][Full Text] [Related]
15. (Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptor.
Yamada K; Rice KC; Flippen-Anderson JL; Eissenstat MA; Ward SJ; Johnson MR; Howlett AC
J Med Chem; 1996 May; 39(10):1967-74. PubMed ID: 8642555
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.
Rodríguez de Fonseca F; Gorriti MA; Fernández-Ruiz JJ; Palomo T; Ramos JA
Pharmacol Biochem Behav; 1994 Jan; 47(1):33-40. PubMed ID: 8115426
[TBL] [Abstract][Full Text] [Related]
17. 1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor.
Huffman JW; Bushell SM; Miller JR; Wiley JL; Martin BR
Bioorg Med Chem; 2002 Dec; 10(12):4119-29. PubMed ID: 12413866
[TBL] [Abstract][Full Text] [Related]
18. Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes.
Westphal MV; Sarott RC; Zirwes EA; Osterwald A; Guba W; Ullmer C; Grether U; Carreira EM
Chemistry; 2020 Jan; 26(6):1380-1387. PubMed ID: 31961047
[TBL] [Abstract][Full Text] [Related]
19. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
Kaminski NE; Abood ME; Kessler FK; Martin BR; Schatz AR
Mol Pharmacol; 1992 Nov; 42(5):736-42. PubMed ID: 1279376
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
